THJ-2201

THJ-2201
Legal status
Legal status	CA: Schedule II; DE: Anlage II (Authorized trade only, not prescriptible); UK: Class B; US: Schedule I;
Identifiers
	IUPAC name [1-(5-Fluoropentyl)-1H-indazol-3-yl](1-naphthyl)methanone;
CAS Number	1801552-01-1 ;
PubChem CID	91864533;
ChemSpider	30646749;
UNII	D7P051IW0T;
CompTox Dashboard (EPA)	DTXSID901010029 ;
Chemical and physical data
Formula	C23H21FN2O
Molar mass	360.432 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c1ccc2c(c1)cccc2C(=O)c3c4ccccc4n(n3)CCCCCF;
	InChI InChI=1S/C23H21FN2O/c24-15-6-1-7-16-26-21-14-5-4-12-20(21)22(25-26)23(27)19-13-8-10-17-9-2-3-11-18(17)19/h2-5,8-14H,1,6-7,15-16H2; Key:DULWRYKFTVFPTL-UHFFFAOYSA-N;

THJ-2201 is an indazole-based synthetic cannabinoid that presumably acts as a potent agonist of the CB₁ receptor and has been sold online as a designer drug.

It is a structural analog of AM-2201 in which the central indole ring has been replaced by indazole.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.